Hide filtersShow filters × Close Deal DID Agency Bryan, Garnier & Co acts as Joint Bookrunner on Swedish Stirling’s SEK 225 million Follow-on Offering Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Carbios on its EUR 114 million Publicly Marketed Follow-on Offering Bryan, Garnier & Co advises Halma on its acquisition of PeriGen Bryan, Garnier & Co acts as Joint Bookrunner to Valneva on its USD 108 million Nasdaq Initial Public Offering Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Laboratoires Majorelle on the sale of a majority stake to EW Healthcare Partners Bryan, Garnier & Co acts as Sole Financial Advisor to French telemedicine leader Qare on its acquisition by European digital health provider HealthHero Bryan, Garnier & Co acts as Advisor to the Shareholders of Advania on its majority sale to Goldman Sachs funds Bryan, Garnier & Co acts as European Lead Manager to Humanigen on its USD 100.4 million Marketed Follow-on Offering Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner to LMK Group on its SEK 550 million Initial Public Offering Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to GenSight on its EUR 30 million Follow-on Offering Bryan, Garnier & Co acts as Joint Bookrunner to Azelio on its SEK 596 million Follow-on Offering
